Red cell distribution width and contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention
Dear Editor, The recent report by Akkoyun et al. on red cell distribution width (RDW) and contrast-induced nephropathy (CIN) in patients who underwent primary percutaneous coronary intervention (PCI) is very interesting. [1] Akkoyun et al. found that, "Compared to the CINnegative group, CIN-positive patients had increased RDW values." [1] The authors concluded that RDW was an independent predictor of CIN in patients who underwent PCI. [1] This conclusion was also reached in a recent study by Kurtul et al. [2] Indeed, while RDW values may be useful, several concerns exist regarding the measurement of RDW. First, RDW values obtained from various kinds of automated hematology analyzers are usually different. [3] For example, Bollinger et al. found poor correlation between RDW values obtained from an automated hematology analyzer, a Technicon H1, and instrumentation reference. [4] In addition, many pathophysiological factors such as anemia [5] and smoking [6] can cause deviations in RDW results.
Dear Editor,
We would like to thank the authors for their comments and criticism of our original investigation, entitled "Red cell distribution width and contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention." [1] We concluded that the group positive for contrast-induced nephropathy (CIN) had higher red cell distribution width (RDW) than the CIN-negative group. As mentioned, this result was supported by the findings of Kurtul et al. [2] Indeed, measurement of RDW may be affected by factors including anemia and smoking, and may differentiate when obtained using an automated hematology analyzer. [1] We have the following comments and concerns.
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LVHT is frequently associated with genetic disorders, particularly chromosomal defects, primary cardiomyopathies, and neuromuscular disorders. [2, 3] Did the authors consider a double trouble in the presented patient? Genetic disorders most frequently associated with LVHT are mitochondrial disorders. [2] Were there any indications for muscle disease, such as muscle cramps, easy fatigability, exercise intolerance, myotonia, myalgia, wasting, fasciculations, or weakness? Was creatine kinase elevated? Was needle electromyography myopathic? Were there any indications for multisystem disease? Were organs or tissues other than the skin or heart affected? Were there indications for pancytopenia or eosinophilia? Were there other congenital defects or dysmorphism? Was there consanguinity of the parents?
As LVHT occurs familiarly, [4] it is essential to know whether LVHT is present in other family members. Were cardiac symptoms or signs reported in any firstdegree relative? Were first-degree relatives systematically screened for LVHT? As LVHT may remain asymptomatic for years in a number of patients, there is a need to actively search for it.
As the right ventricle is physiologically hypertrabeculated, and no cut-off is available to differentiate between normal and abnormal hypertrabeculation of the right ventricle, noncompaction of the right ventricle or biventricular noncompaction should not be diagnosed. So far, noncompaction is an abnormality exclusively of the left ventricle.
Cutaneous sclerosis in association with LVHT has been described in a 75-year-old male. [5] In addition to LVHT and systemic sclerosis, this patient presented with anemia, leukopenia, thrombocytopenia, cataract, ptosis, myopathy, and polyneuropathy. [5] He died 5 months after diagnosis. Were any of these abnormalities observed in the patient currently presented?
Scleroderma may be associated with malignancy. Was the patient investigated for occult neoplasia? Was the history positive for previous malignancy? Were there clinical indications for neoplasm, such as nightly sweating, weight loss, anemia, fatigue, or adenoma? Systemic sclerosis is frequently associated with myocarditis. Did the presented patient undergo cardiac MRI with contrast medium to aid in the search for myocarditis, or was an endomyocardial biopsy performed? Was late gadolinium enhancement, indicating myocardial fibrosis, found on cardiac MRI? Did the patient receive any type of treatment? Did treatment of systemic sclerosis also affect the cardiac abnormalities?
Overall, this interesting case should be supplemented with information regarding genetic background, investigation of other family members for LVHT, and findings of cardiac MRI or endomyocardial biopsy. LVHT may be causally unrelated to systemic sclerosis and may be due to a second subclinical or mildly manifesting second genetic trouble.
